We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Flavors Gears Up to Report Q4 Earnings: What to Expect?
Read MoreHide Full Article
International Flavors & Fragrances Inc. (IFF - Free Report) is scheduled to report fourth-quarter 2024 results on Feb. 18, after the closing bell.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
The Zacks Consensus Estimate for IFF’s revenues is pegged at $2.67 billion, indicating a 1.37% dip from the year-ago reported figure.
The consensus estimate for earnings is pegged at 78 cents per share. The consensus estimate for IFF’s earnings has moved down 2.5% in the past 60 days. The estimate indicates year-over-year growth of 8.3%.
Image Source: Zacks Investment Research
IFF’s Earnings Surprise History
International Flavors’ earnings beat the Zacks Consensus Estimates in two of the trailing four quarters and missed in two, the average surprise being a positive 10.9%.
Image Source: Zacks Investment Research
What the Zacks Model Unveils for International Flavors
Our model predicts an earnings beat for International Flavors this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is precisely the case here.
Earnings ESP: IFF has an Earnings ESP of +3.33%. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Factors Likely to Have Shaped IFF’s Q4 Performance
The company has been witnessing volume growth with broad-based contributions across each of its businesses. International Flavors’s results are likely to reflect the overall improvement in its sales performance. IFF’s ongoing efforts to improve productivity and reduce costs are likely to have benefited its margins.
However, International Flavors continues to incur high raw material costs and additional costs related to labor, shipping and cleaning. Despite its pricing actions and focused cost reduction efforts, these factors are likely to have dented margins in the to-be-reported quarter. International Flavors’ manufacturing costs are expected to increase to support higher demand.
Projections for International Flavors’ Segments in Q4
Our model estimates the Nourish segment’s fourth-quarter sales to decline 2.1% year over year to $1.36 billion. The segment’s operating EBITDA is projected at $160 million, indicating a fall of 3% from the year-ago quarter’s actual.
We expect the Scent segment’s sales to decrease 5.5% year over year to $546 million. The ongoing momentum in Consumer Fragrance, as well as improvement in Fragrance Ingredients and Fine Fragrance, is likely to have aided its performance. Our estimate for the segment’s quarterly operating EBITDA is $101 million, indicating a year-over-year decrease of 6.9%.
The projection for the Health & Biosciences segment’s sales is $537 million, indicating a 1.7% increase from the year-ago quarter’s reported figure, reflecting the ongoing momentum in its businesses. We expect operating EBITDA to decrease 6.4% to $152 million.
The Pharma Solutions segment’s sales are projected to inch up 0.2% year over year to $203 million as volume growth will be somewhat offset by lower pricing. The segment's operating EBITDA is expected to fall 9% from the year-ago reported figure to $24 million. Volume growth and productivity gains are likely to have been offset by an unfavorable mix.
IFF Stock’s Price Performance
In the past year, International Flavors’ shares have gained 6.8% against the industry’s 15.7% decline.
Image Source: Zacks Investment Research
Other Stocks to Consider
Here are some other companies in the basic materials space, which, according to our model, have the right combination of elements to post an earnings beat this quarter.
CF Industries Holdings, Inc. (CF - Free Report) , scheduled to release its fourth-quarter 2024 earnings on Feb. 18, has an Earnings ESP of +1.25% and a Zacks Rank #3 at present.
The Zacks Consensus Estimate for CF’s fourth-quarter earnings is pegged at $1.49. It has a trailing four-quarter average surprise of 10.3%.
Avient Corporation (AVNT - Free Report) , ready to release earnings numbers on Feb. 13, currently has an Earnings ESP of +0.11% and a Zacks Rank #3.
The Zacks Consensus Estimate for AVNT’s fourth-quarter 2024 earnings is pegged at 48 cents. It has a trailing four-quarter average surprise of 7.4%.
Kinross Gold Corporation (KGC - Free Report) , scheduled to release its fourth-quarter 2024 on Feb. 12, has an Earnings ESP of +17.02% and a Zacks Rank of 3 at present.
The Zacks Consensus Estimate for KGC’s fourth-quarter 2024 earnings is pegged at 23 cents per share. It has a trailing four-quarter average surprise of 32.5%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
International Flavors Gears Up to Report Q4 Earnings: What to Expect?
International Flavors & Fragrances Inc. (IFF - Free Report) is scheduled to report fourth-quarter 2024 results on Feb. 18, after the closing bell.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
The Zacks Consensus Estimate for IFF’s revenues is pegged at $2.67 billion, indicating a 1.37% dip from the year-ago reported figure.
The consensus estimate for earnings is pegged at 78 cents per share. The consensus estimate for IFF’s earnings has moved down 2.5% in the past 60 days. The estimate indicates year-over-year growth of 8.3%.
IFF’s Earnings Surprise History
International Flavors’ earnings beat the Zacks Consensus Estimates in two of the trailing four quarters and missed in two, the average surprise being a positive 10.9%.
What the Zacks Model Unveils for International Flavors
Our model predicts an earnings beat for International Flavors this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is precisely the case here.
Earnings ESP: IFF has an Earnings ESP of +3.33%. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Zacks Rank: The company currently sports a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Factors Likely to Have Shaped IFF’s Q4 Performance
The company has been witnessing volume growth with broad-based contributions across each of its businesses. International Flavors’s results are likely to reflect the overall improvement in its sales performance. IFF’s ongoing efforts to improve productivity and reduce costs are likely to have benefited its margins.
However, International Flavors continues to incur high raw material costs and additional costs related to labor, shipping and cleaning. Despite its pricing actions and focused cost reduction efforts, these factors are likely to have dented margins in the to-be-reported quarter. International Flavors’ manufacturing costs are expected to increase to support higher demand.
Projections for International Flavors’ Segments in Q4
Our model estimates the Nourish segment’s fourth-quarter sales to decline 2.1% year over year to $1.36 billion. The segment’s operating EBITDA is projected at $160 million, indicating a fall of 3% from the year-ago quarter’s actual.
We expect the Scent segment’s sales to decrease 5.5% year over year to $546 million. The ongoing momentum in Consumer Fragrance, as well as improvement in Fragrance Ingredients and Fine Fragrance, is likely to have aided its performance. Our estimate for the segment’s quarterly operating EBITDA is $101 million, indicating a year-over-year decrease of 6.9%.
The projection for the Health & Biosciences segment’s sales is $537 million, indicating a 1.7% increase from the year-ago quarter’s reported figure, reflecting the ongoing momentum in its businesses. We expect operating EBITDA to decrease 6.4% to $152 million.
The Pharma Solutions segment’s sales are projected to inch up 0.2% year over year to $203 million as volume growth will be somewhat offset by lower pricing. The segment's operating EBITDA is expected to fall 9% from the year-ago reported figure to $24 million. Volume growth and productivity gains are likely to have been offset by an unfavorable mix.
IFF Stock’s Price Performance
In the past year, International Flavors’ shares have gained 6.8% against the industry’s 15.7% decline.
Image Source: Zacks Investment Research
Other Stocks to Consider
Here are some other companies in the basic materials space, which, according to our model, have the right combination of elements to post an earnings beat this quarter.
CF Industries Holdings, Inc. (CF - Free Report) , scheduled to release its fourth-quarter 2024 earnings on Feb. 18, has an Earnings ESP of +1.25% and a Zacks Rank #3 at present.
The Zacks Consensus Estimate for CF’s fourth-quarter earnings is pegged at $1.49. It has a trailing four-quarter average surprise of 10.3%.
Avient Corporation (AVNT - Free Report) , ready to release earnings numbers on Feb. 13, currently has an Earnings ESP of +0.11% and a Zacks Rank #3.
The Zacks Consensus Estimate for AVNT’s fourth-quarter 2024 earnings is pegged at 48 cents. It has a trailing four-quarter average surprise of 7.4%.
Kinross Gold Corporation (KGC - Free Report) , scheduled to release its fourth-quarter 2024 on Feb. 12, has an Earnings ESP of +17.02% and a Zacks Rank of 3 at present.
The Zacks Consensus Estimate for KGC’s fourth-quarter 2024 earnings is pegged at 23 cents per share. It has a trailing four-quarter average surprise of 32.5%.